BMCM
BVS icon

Burns Matteson Capital Management’s Bioventus BVS Stock Holding History

Burns Matteson Capital Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,629
Closed -$66.9K – 166
2024
Q2 		$66.9K Buy
+11,629
New +$63.8K 0.04% 153

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Burns Matteson Capital Management's BVS Position: Q3 2024 in Review

Burns Matteson Capital Management sold out of Bioventus (BVS) in Q3 2024, closing a stake of 11,629 shares — an estimated $66.9K sold.

Burns Matteson Capital Management first reported a position in BVS in Q2 2024 and held it in 1 quarter. The position peaked at $66.9K in Q2 2024. 138 funds tracked by Wall St. Rank hold BVS as of Q3 2024.

  • Burns Matteson Capital Management reported no remaining Bioventus position as of Q3 2024 after selling out during the quarter.
  • Burns Matteson Capital Management sold 11,629 Bioventus shares in Q3 2024, an estimated $66.9K.
  • Burns Matteson Capital Management first reported a position in Bioventus in Q2 2024 and held it in 1 quarter.
  • Burns Matteson Capital Management's Bioventus position peaked at $66.9K in Q2 2024.
  • 138 funds tracked by Wall St. Rank held Bioventus as of Q3 2024.

Based on Burns Matteson Capital Management's 13F filing for Q3 2024, filed 10 Oct 2024.